ITGB1 and metastatic malignant neoplasm in the lymph nodes: The patients in the ITGB1 high-expression group were significantly older and had higher CA19-9 levels (p = 0.037 and 0.039, respectively), but other clinicopathological factors such as preoperative tumor marker levels and lymph node metastasis were not significantly different (Table 1).